Upon intranasal vesicular stomatitis virus infection, astrocytes in the olfactory bulb are important interferon beta producers that protect from lethal encephalitis

Journal of Virology

Volumn 89, Issue 5, 2015, Pages 2731-2738

  Detje, Claudia N ^a   Lienenklaus, Stefan ^b   Chhatbar, Chintan ^a   Spanier, Julia ^a   Prajeeth, Chittappen K ^c   Soldner, Claudia ^a   Tovey, Michael G ^d   Schlüter, Dirk ^b,e   Weiss, Siegfried ^b   Stangel, Martin ^c   Kalinke, Ulrich ^a  

^a INSTITUTE OF INFECTION IMMUNOLOGY   (Germany)

^b HELMHOLTZ CENTRE FOR INFECTION RESEARCH   (Germany)

^c HANNOVER MEDICAL SCHOOL   (Germany)

^d Ecole Normale Superieure de Cachan   (France)

^e OTTO VON GUERICKE UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BETA INTERFERON; ENHANCED GREEN FLUORESCENT PROTEIN; LUCIFERASE; GREEN FLUORESCENT PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTROCYTE; BRAIN REGION; CELL FUNCTION; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENCEPHALITIS; MOLECULAR DYNAMICS; MOUSE; NEUROPROTECTION; NONHUMAN; OLFACTORY BULB; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; VESICULAR STOMATITIS; VESICULOVIRUS; VIRUS IDENTIFICATION; VIRUS INHIBITION; ANIMAL; C57BL MOUSE; DEFICIENCY; DISEASE MODEL; GENE EXPRESSION PROFILING; GENETICS; IMMUNOLOGY; KNOCKOUT MOUSE; NERVE CELL; REPORTER GENE; RHABDOVIRUS INFECTION; SECRETION (PROCESS); SURVIVAL ANALYSIS; VIROLOGY; VIRUS ENCEPHALITIS;

MUS; VESICULAR STOMATITIS VIRUS;

ANIMALS; ASTROCYTES; DISEASE MODELS, ANIMAL; ENCEPHALITIS, VIRAL; GENE EXPRESSION PROFILING; GENES, REPORTER; GREEN FLUORESCENT PROTEINS; INTERFERON-BETA; LUCIFERASES; MICE, INBRED C57BL; MICE, KNOCKOUT; NEURONS; OLFACTORY BULB; RHABDOVIRIDAE INFECTIONS; SURVIVAL ANALYSIS; VESICULOVIRUS;

EID: 84923064724     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.02044-14     Document Type: Article

References (34)

1. Sorgeloos F, Kreit M, Hermant P, Lardinois C, Michiels T. 2013. Antiviral type I and type III interferon responses in the central nervous system. Viruses 5:834-857. http://dx.doi.org/10.3390/v5030834.
2. Griffin DE. 2003. Immune responses to RNA-virus infections of the CNS. Nat Rev Immunol 3:493-502. http://dx.doi.org/10.1038/nri1105.
3. Dietzschold B, Rupprecht CE, Fu ZF, Koprowski H, Fields BN, Knipe DM, Howley PM. 1996. Rhabdoviruses, p 1137-1159. In Virology. Lippincott-Raven Publishers, Philadelphia, PA.
4. Detje CN, Meyer T, Schmidt H, Kreuz D, Rose JK, Bechmann I, Prinz M, Kalinke U. 2009. Local type I IFN receptor signaling protects against virus spread within the central nervous system. J Immunol 182:2297-2304. http://dx.doi.org/10.4049/jimmunol.0800596.
5. Bi Z, Barna M, Komatsu T, Reiss CS. 1995. Vesicular stomatitis virus infection of the central nervous system activates both innate and acquired immunity. J Virol 69:6466-6472.
6. Barchet W, Cella M, Odermatt B, Asselin-Paturel C, Colonna M, Kalinke U. 2002. Virus-induced interferon alpha production by a dendritic cell subset in the absence of feedback signaling in vivo. J Exp Med 195:507-516. http://dx.doi.org/10.1084/jem.20011666.
7. Asselin-Paturel C, Boonstra A, Dalod M, Durand I, Yessaad N, Dezutter-Dambuyant C, Vicari A, O'Garra A, Biron C, Briere F, Trinchieri G. 2001. Mouse type I IFN-producing cells are immature APCs with plasmacytoid morphology. Nat Immunol 2:1144-1150. http://dx.doi.org/10.1038/ni736.
8. Greter M, Heppner FL, Lemos MP, Odermatt BM, Goebels N, Laufer T, Noelle RJ, Becher B. 2005. Dendritic cells permit immune invasion of the CNS in an animal model of multiple sclerosis. Nat Med 11:328-334. http://dx.doi.org/10.1038/nm1197.
9. Kallfass C, Ackerman A, Lienenklaus S, Weiss S, Heimrich B, Staeheli P. 2012. Visualizing production of beta interferon by astrocytes and microglia in brain of La Crosse virus-infected mice. J Virol 86:11223-11230. http://dx.doi.org/10.1128/JVI.01093-12.
10. Kallfass C, Lienenklaus S, Weiss S, Staeheli P. 2013. Visualizing the beta interferon response in mice during infection with influenza A viruses expressing or lacking nonstructural protein 1. J Virol 87:6925-6930. http://dx.doi.org/10.1128/JVI.00283-13.
11. Delhaye S, Paul S, Blakqori G, Minet M, Weber F, Staeheli P, Michiels T. 2006. Neurons produce type I interferon during viral encephalitis. Proc Natl Acad Sci USA 103:7835-7840. http://dx.doi.org/10.1073/pnas.0602460103.
12. van den Pol AN, Ding S, Robek MD. 2014. Long-distance interferon signaling within the brain blocks virus spread. J Virol 88:3695-3704. http://dx.doi.org/10.1128/JVI.03509-13.
13. Akwa Y, Hassett DE, Eloranta ML, Sandberg K, Masliah E, Powell H, Whitton JL, Bloom FE, Campbell IL. 1998. Transgenic expression of IFN-alpha in the central nervous system of mice protects against lethal neurotropic viral infection but induces inflammation and neurodegeneration. J Immunol 161:5016-5026.
14. Sandberg K, Eloranta ML, Campbell IL. 1994. Expression of alpha/beta interferons (IFN-alpha/beta) and their relationship to IFN-alpha/betainduced genes in lymphocytic choriomeningitis. J Virol 68:7358-7366.
15. Erlandsson L, Blumenthal R, Eloranta ML, Engel H, Alm G, Weiss S, Leanderson T. 1998. Interferon-beta is required for interferon-alpha production in mouse fibroblasts. Curr Biol 8:223-226. http://dx.doi.org/10.1016/S0960-9822(98)70086-7.
16. Lienenklaus S, Cornitescu M, Zietara N, Lyszkiewicz M, Gekara N, Jablonska J, Edenhofer F, Rajewsky K, Bruder D, Hafner M, Staeheli P, Weiss S. 2009. Novel reporter mouse reveals constitutive and inflammatory expression of IFN-beta in vivo. J Immunol 183:3229-3236. http://dx.doi.org/10.4049/jimmunol.0804277.
17. Tovey MG, Lallemand C, Meritet JF, Maury C. 2006. Adjuvant activity of alpha interferon: mechanism(s) of action. Vaccine 24(Suppl 2):S42-S47.
18. Solodova E, Jablonska J, Weiss S, Lienenklaus S. 2011. Production of IFN-beta during Listeria monocytogenes infection is restricted to monocyte/macrophage lineage. PLoS One 6:e18543. http://dx.doi.org/10.1371/journal.pone.0018543.
19. Tronche F, Kellendonk C, Kretz O, Gass P, Anlag K, Orban PC, Bock R, Klein R, Schutz G. 1999. Disruption of the glucocorticoid receptor gene in the nervous system results in reduced anxiety. Nat Genet 23:99-103. http://dx.doi.org/10.1038/12703.
20. Zhu Y, Romero MI, Ghosh P, Ye Z, Charnay P, Rushing EJ, Marth JD, Parada LF. 2001. Ablation of NF1 function in neurons induces abnormal development of cerebral cortex and reactive gliosis in the brain. Genes Dev 15:859-876. http://dx.doi.org/10.1101/gad.862101.
21. Bajenaru ML, Zhu Y, Hedrick NM, Donahoe J, Parada LF, Gutmann DH. 2002. Astrocyte-specific inactivation of the neurofibromatosis 1 gene (NF1) is insufficient for astrocytoma formation. Mol Cell Biol 22:5100-5113. http://dx.doi.org/10.1128/MCB.22.14.5100-5113.2002.
22. Hövelmeyer N, Hao Z, Kranidioti K, Kassiotis G, Buch T, Frommer F, von Hoch L, Kramer D, Minichiello L, Kollias G, Lassmann H, Waisman A. 2005. Apoptosis of oligodendrocytes via Fas and TNF-R1 is a key event in the induction of experimental autoimmune encephalomyelitis. J Immunol 175: 5875-5884. http://dx.doi.org/10.4049/jimmunol.175.9.5875.
23. Kotsiari A, Voss EV, Pul R, Skripuletz T, Ragancokova D, Trebst C, Stangel M. 2010. Interferon-beta treatment normalizes the inhibitory effect of serum from multiple sclerosis patients on oligodendrocyte progenitor proliferation. Neurosci Lett 485:107-111. http://dx.doi.org/10.1016/j.neulet.2010.08.075.
24. Hothorn T, Bretz F, Westfall P. 2008. Simultaneous inference in general parametric models. Biometrical J 50:346-363. http://dx.doi.org/10.1002/bimj.200810425.
25. Honda K, Yanai H, Takaoka A, Taniguchi T. 2005. Regulation of the type I IFN induction: a current view. Int Immunol 17:1367-1378. http://dx.doi.org/10.1093/intimm/dxh318.
26. Malmgaard L. 2004. Induction and regulation of IFNs during viral infections. J Interferon Cytokine Res 24:439-454. http://dx.doi.org/10.1089/1079990041689665.
27. Marie I, Durbin JE, Levy DE. 1998. Differential viral induction of distinct interferon-alpha genes by positive feedback through interferon regulatory factor-7. EMBO J 17:6660-6669. http://dx.doi.org/10.1093/emboj/17.22.6660.
28. Burdeinick-Kerr R, Wind J, Griffin DE. 2007. Synergistic roles of antibody and interferon in noncytolytic clearance of Sindbis virus from different regions of the central nervous system. J Virol 81:5628-5636. http://dx.doi.org/10.1128/JVI.01152-06.
29. Gerlach N, Schimmer S, Weiss S, Kalinke U, Dittmer U. 2006. Effects of type I interferons on Friend retrovirus infection. J Virol 80:3438-3444. http://dx.doi.org/10.1128/JVI.80.7.3438-3444.2006.
30. Trottier MD, Lyles DS, Reiss CS. 2007. Peripheral, but not central nervous system, type I interferon expression in mice in response to intranasal vesicular stomatitis virus infection. J Neurovirol 13:433-445. http://dx.doi.org/10.1080/13550280701460565.
31. Bush TG, Puvanachandra N, Horner CH, Polito A, Ostenfeld T, Svendsen CN, Mucke L, Johnson MH, Sofroniew MV. 1999. Leukocyte infiltration, neuronal degeneration, and neurite outgrowth after ablation of scar-forming, reactive astrocytes in adult transgenic mice. Neuron 23: 297-308. http://dx.doi.org/10.1016/S0896-6273(00)80781-3.
32. Kasowski HJ, Kim H, Greer CA. 1999. Compartmental organization of the olfactory bulb glomerulus. J Comp Neurol 407:261-274. http://dx.doi.org/10.1002/(SICI)1096-9861(19990503)407:2<261::AID-CNE7>3.3.CO;2-7.
33. Andersen JB, Sternberg C, Poulsen LK, Bjorn SP, Givskov M, Molin S. 1998. New unstable variants of green fluorescent protein for studies of transient gene expression in bacteria. Appl Environ Microbiol 64:2240-2246.
34. Lazear HM, Pinto AK, Vogt MR, Gale M, Jr, Diamond MS. 2011. Beta interferon controls West Nile virus infection and pathogenesis in mice. J Virol 85:7186-7194. http://dx.doi.org/10.1128/JVI.00396-11.